5''-CHA); 2.56 (1H, dd, J = 17.4, J = 5.7, 4-CHB); 2.20-2.08 (1H, m, 5''-CHB). Mass spectrum, m/z (Irel, %): 467
(28), 466(28), 465 [M]+ (100), 327 (11), 301 (13), 299 (20). Found, %: С 64.52; Н 4.61; N 9.08.
C25H21ClFN3O3. Calculated, %: C 64.45; H 4.54; N 9.02.
3-{2-[3-(4-Methoxybenzylidene)-2-oxocyclohexylidene]imidazolidin-1-yl}-1-(4-methylphenyl)-
pyrrolidine-2,5-dione (7a) was obtained analogously to the phenylacetamide 5a. Yield 0.43 g (82%); mp
197-199°С. 1H NMR spectrum (DMSO-d6), δ, ppm (J, Hz): 10.22 (1H, s, NH); 7.51 (2H, d, J = 7.4, H Ar); 7.42
(2H, d, J = 7.7, H Ar); 7.36 (1H, s, =CH); 7.10 (2H, d, J = 7.6, H Ar); 7.03 (2H, d, J = 8.0, H Ar); 3.82 (3H, s,
CH3O); 3.80-3.62 (4H, m, NCH2CH2N); 3.56-3.48 (1H, m, 3-CH); 3.03-2.93 (1H, m) and 2.86-2.76 (1H, m,
4''-CH2); 2.73-2.55 (3H, m, 4-CH2, 6''-CHA); 2.24 (3H, s, ArCH3); 2.17-2.04 (1H, m, 6''-CHB); 2.00-1.78 (2H,
m, 5''-CH2). 13C NMR spectrum (DMSO-d6), δ, ppm: 199.3; 169.1; 165.9; 160.4; 159.9; 137.1; 136.39; 134.1;
133.3; 132.8; 129.6; 128.0; 119.9; 114.6; 55.8; 53.0; 51.4; 43.4; 43.2; 32.6; 29.7; 28.8; 20.9; 18.8. Found, %:
С 71.42; Н 6.23; N 9.02. C28H29N3O4. Calculated, %: C 71.32; H 6.20; N 8.91.
3-{2-[3-(4-Methoxybenzylidene)-2-oxocyclohexylidene]imidazolidin-1-yl}-1-(2,5-dimethylphenyl)-
pyrrolidine-2,5-dione (7b) was obtained analogously to the phenylacetamide 5a. Yield 0.46 g (85%); mp
196-198°С. NMR spectrum 1H (DMSO-d6), δ, ppm (J, Hz): 9.68 (1H, s, NH); 7.51 (2H, d, J = 8.6, H Ar); 7.39
(1H, s, =CH); 7.09-6.96 (5H, m, H Ar); 3.82 (3H, s, CH3O); 3.80-3.60 (5H, m, NCH2CH2N, 3-CH); 2.95-2.85
(2H, m, 4''-CH2); 2.73 (1H, dd, J = 13.1, J = 5.0) and 2.64 (1H, dd, J = 11.8, J = 5.0, 4-CH2); 2.50-2.45 (1Н, m)
and 2.04-1.97 (1Н, m, 6''-CH2); 2.24 (3H, s, ArCH3); 2.21-2.14 (1H, m) and 1.95-1.86 (1H, m, 5''-CH2); 2.05
(3H, s, ArCH3). Mass spectrum, m/z (Irel, %): 486 (4), 485 [M]+ (8), 337 (6), 309 (13), 149 (25), 121 (30), 62
(100). Found, %: С 71.69; Н 6.45; N 8.69. C29H31N3O4. Calculated, %: C 71.73; H 6.43; N 8.65.
3-{2-[3-(4-Methoxybenzylidene)-2-oxocyclohexylidene]imidazolidin-1-yl}-1-(3-fluorophenyl)pyrro-
lidine-2,5-dione (7c) was obtained analogously to the phenylacetamide 5a. Yield 0.39 g (73%); mp 207-209°С.
1H NMR spectrum (DMSO-d6), δ, ppm (J, Hz): 10.62 (1H, s, NH); 7.56-7.48 (3H, m, H Ar); 7.38 (1H, s, =CH);
7.35-7.31 (1H, m, H Ar); 7.28 (1H, d, J = 8.3, H Ar); 7.03 (2H, d, J = 8.7, H Ar); 6.93-6.87 (1H, m, H Ar);
3.92-3.62 (7H, m, CH3O, NCH2CH2N); 3.55 (1H, t, J = 5.0, 3-CH); 3.02-2.92 (1H, m) and 2.88-2.78 (1H, m,
4''-CH2); 2.72 (1H, dd, J = 18.2, J = 5.0) and 2.65 (1H, dd, J = 17.1, J = 5.0, 4-CH2); 2.49-2.41 (1H, m) and
2.18-2.08 (1H, m, 6''-CH2); 1.98-1.80 (2H, m, 5''-CH2). Mass spectrum, m/z (Irel, %): 476 (9), 475 [M]+ (20), 337
(50), 309 (100). Found, %: С 68.24; Н 5.57; N 8.90. C27H26FN3O4. Calculated, %: C 68.20; H 5.51; N 8.84.
8-Benzoyl-5-oxo-1,2,3,5-tetrahydroimidazo[1,2-a]pyridine-7-carboxylic Acid Methyl Ester (8a). A
mixture of acetophenone 1a (0.36 g, 1.9 mmol) and DMAD (0.31 g, 2.2 mmol) in acetonitrile (30 ml) was heated
at reflux for 1 h. The precipitate was filtered off, washed with acetonitrile, and dried in air. Yield 0.52 g (92%); mp
187-189°С. 1H NMR spectrum (DMSO-d6), δ, ppm (J, Hz): 8.68 (1H, s, NH); 7.56-7.35 (5H, m, H Ph); 5.74 (1H,
s, H-6); 4.08 (2H, t, J = 9.3, 3-CH2); 3.77 (2H, t, J = 9.2, 2-CH2); 3.01 (3H, s, COOCH3). 13C NMR spectrum
(DMSO-d6), δ, ppm: 191.5; 167.3; 159.9; 156.7; 145.8; 141.0; 131.6; 128.7; 127.9; 106.9; 93.8; 52.2; 43.8; 43.3.
Found, %: С 64.32; Н 4.81; N 9.44. C16H14N2O4. Calculated, %: C 64.42; H 4.73; N 9.39.
8-(4-Methylbenzoyl)-5-oxo-1,2,3,5-tetrahydroimidazo[1,2-a]pyridine-7-carboxylic Acid Methyl Ester
(8b) was obtained analogously to the ester 8a. Yield 0.46 g (78%); mp 183-185°С. 1H NMR spectrum (DMSO-d6),
δ, ppm (J, Hz): 8.58 (1H, s, NH); 7.33 (2H, d, J = 7.7, H Ar); 7.21 (2H, d, J = 7.7, H Ar); 5.73 (1H, s, Н-6); 4.07
(2H, t, J = 9.3, 3-CH2); 3.77 (2H, t, J = 9.2, 2-CH2); 3.04 (3H, s, СООCH3); 2.33 (3H, s, ArCH3). 13C NMR
spectrum (DMSO-d6), δ, ppm: 191.3; 167.3; 159.9; 156.5; 145.8; 141.7; 138.3; 129.2; 128.1; 106.7; 93.9; 52.3;
43.8; 43.2; 21.5. Found, %: С 65.45; Н 5.25; N 9.03. C17H16N2O4. Calculated, %: C 65.38; H 5.16; N 8.97.
8-(4-Bromobenzoyl)-5-oxo-1,2,3,5-tetrahydroimidazo[1,2-a]pyridine-7-carboxylic Acid Methyl
1
Ester (8c) was obtained analogously to the ester 8a. Yield 0.36 g (50%); mp 189-191°С. H NMR spectrum
(DMSO-d6), δ, ppm (J, Hz): 8.70 (1H, s, NH); 7.63 (2H, d, J = 8.4, H Ar); 7.36 (2H, d, J = 8.4, H Ar); 5.76 (1H,
13
s, H-6); 4.07 (2H, t, J = 9.3, 3-CH2); 3.78 (2H, t, J = 9.3, 2-CH2); 3.10 (3H, s, COOCH3). C NMR spectrum
(DMSO-d6), δ, ppm: 190.2; 167.2; 159.9; 156.7; 145.5; 140.1; 131.7; 130.0; 125.2; 107.2; 93.6; 52.4; 43.8;
43.3. Found, %: С 50.85; Н 3.44; N 7.51. C16H13BrN2O4. Calculated, %: C 50.95; H 3.47; N 7.43.
1210